Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henryk Mach

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2011
Addressing new analytical challenges in protein formulation developmentHenryk Mach, Tudor Arvinte
Journal of Pharmaceutical Sciences|October 2, 2013
Ultraviolet spectroscopy as a tool in therapeutic protein developmentHenryk Mach, C Russell Middaugh
Journal of Pharmaceutical Sciences|July 24, 2010
Monoclonal antibody aggregation intermediates visualized by atomic force microscopyHanjoo Lee, Marc Kirchmeier, Henryk Mach
Therapeutic Delivery|August 21, 2012
High-dose monoclonal antibodies via the subcutaneous route: challenges and technical solutions, an industry perspectiveChakravarthy Narasimhan, Henryk Mach, Mohammed Shameem
Journal of Pharmaceutical Sciences|April 15, 2011
High throughput formulation screening for global aggregation behaviors of three monoclonal antibodiesYi Li, Henryk Mach, Jeffrey T Blue
Mabs|April 11, 2013
Aggregation of biopharmaceuticals in human plasma and human serum: implications for drug research and developmentTudor Arvinte, Caroline Palais, Erin Green-Trexler, et al.
Therapeutic Delivery|July 24, 2012
Electrostatic interactions of monoclonal antibodies with subcutaneous tissueHenryk Mach, Sonia M Gregory, Alexis Mackiewicz, et al.
Journal of Pharmaceutical Sciences|July 28, 2006
Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs)Henryk Mach, David B Volkin, Robert D Troutman, et al.
Journal of Pharmaceutical Sciences|March 5, 2011
The use of flow cytometry for the detection of subvisible particles in therapeutic protein formulationsHenryk Mach, Akhilesh Bhambhani, Brian K Meyer, et al.
Vaccine|June 22, 2014
Detecting and preventing reversion to toxicity for a formaldehyde-treated C. difficile toxin B mutantBei Wang, Su Wang, Richard R Rustandi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2011
Addressing new analytical challenges in protein formulation developmentHenryk Mach, Tudor Arvinte
Journal of Pharmaceutical Sciences|October 2, 2013
Ultraviolet spectroscopy as a tool in therapeutic protein developmentHenryk Mach, C Russell Middaugh
Journal of Pharmaceutical Sciences|July 24, 2010
Monoclonal antibody aggregation intermediates visualized by atomic force microscopyHanjoo Lee, Marc Kirchmeier, Henryk Mach
Therapeutic Delivery|August 21, 2012
High-dose monoclonal antibodies via the subcutaneous route: challenges and technical solutions, an industry perspectiveChakravarthy Narasimhan, Henryk Mach, Mohammed Shameem
Journal of Pharmaceutical Sciences|April 15, 2011
High throughput formulation screening for global aggregation behaviors of three monoclonal antibodiesYi Li, Henryk Mach, Jeffrey T Blue
Mabs|April 11, 2013
Aggregation of biopharmaceuticals in human plasma and human serum: implications for drug research and developmentTudor Arvinte, Caroline Palais, Erin Green-Trexler, et al.
Therapeutic Delivery|July 24, 2012
Electrostatic interactions of monoclonal antibodies with subcutaneous tissueHenryk Mach, Sonia M Gregory, Alexis Mackiewicz, et al.
Journal of Pharmaceutical Sciences|July 28, 2006
Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs)Henryk Mach, David B Volkin, Robert D Troutman, et al.
Journal of Pharmaceutical Sciences|March 5, 2011
The use of flow cytometry for the detection of subvisible particles in therapeutic protein formulationsHenryk Mach, Akhilesh Bhambhani, Brian K Meyer, et al.
Vaccine|June 22, 2014
Detecting and preventing reversion to toxicity for a formaldehyde-treated C. difficile toxin B mutantBei Wang, Su Wang, Richard R Rustandi, et al.
Pageof 2